Chrishan Anketell

Stock Analyst at Aegis Capital

(n/a)
# 4,374
Out of 4,736 analysts
1
Total ratings
n/a
Success rate
-58.26%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Chrishan Anketell

Can-Fite BioPharma
Jun 24, 2021
Initiates: Buy
Price Target: $50
Current: $1.58
Upside: +3,064.56%